Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001654954-18-013285
Filing Date
2018-11-28
Accepted
2018-11-28 14:36:58
Documents
1
Period of Report
2018-11-28

Document Format Files

Seq Description Document Type Size
1 INFORMATION STATEMENT sbfm_14c.htm PRE 14C 91533
  Complete submission text file 0001654954-18-013285.txt   92834
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: PRE 14C | Act: 34 | File No.: 000-52898 | Film No.: 181205300
SIC: 8731 Services-Commercial Physical & Biological Research